David R. Liu serves as Executive at Prime Medicine, Inc., where they oversee executive responsibilities. Since joining the company, David R. Liu has executed 4 insider transactions totaling $52.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 30, 2025 involved purchasing 21,000 shares valued at $52.9K.
David R. Liu currently holds 20,240,945 shares of Prime Medicine, Inc. (PRME), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David R. Liu has been a net buyer of PRME stock. They have purchased $52.9K and sold $0 worth of shares.
David R. Liu's most recent insider trade was on Jun 30, 2025, when they purchased 21,000 shares at $2.52 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 21, 2023 | PRME | $0 | Gift | 1,000,000 | $N/A | Discretionary |
| Oct 24, 2022 | PRME | $0 | Conversion | 321,665 | $N/A | Discretionary |